Table of Contents

September 2011; Volume 31,Issue 9

  1. Abe, FUMIE

    1. Panipenem Does Not Alter the Pharmacokinetics of the Active Metabolite of Irinotecan SN-38 and Inactive Metabolite SN-38 Glucuronide (SN-38G) in Rats
      AYAKO KATO, JUN UEYAMA, FUMIE ABE, KAZUO HOTTA, IKUTO TSUKIYAMA, TAEYUKI OSHIMA, FUMIO KONDO, HIROKO SAITO and TAKAAKI HASEGAWA
      Anticancer Research September 2011, 31 (9) 2915-2922;

  2. Abou-elkacem, LOTFI

    1. Comparison of μCT, MRI and Optical Reflectance Imaging for Assessing the Growth of GFP/RFP-expressing Tumors
      LOTFI ABOU-ELKACEM, FELIX GREMSE, STEFAN BARTH, ROBERT M. HOFFMAN, FABIAN KIESSLING and WILTRUD LEDERLE
      Anticancer Research September 2011, 31 (9) 2907-2913;

  3. Abujamra, ANA L.

    1. Histone Deacetylase Inhibitors Reverse CpG Methylation by Regulating DNMT1 through ERK Signaling
      SIBAJI SARKAR, ANA L. ABUJAMRA, JENNY E. LOEW, LORA W. FORMAN, SUSAN P. PERRINE and DOUGLAS V. FALLER
      Anticancer Research September 2011, 31 (9) 2723-2732;

  4. Abuzenadah, ADEL

    1. RASSF1A Methylation is Predictive of Poor Prognosis in Female Breast Cancer in a Background of Overall Low Methylation Frequency
      ABDELBASET BUHMEIDA, ADNAN MERDAD, JOUDAH EL-MAGHRABI, FATIMA AL-THOBAITI, MANAR ATA, AYMAN BUGIS, KARI SYRJÄNEN, ADEL ABUZENADAH, ADEEL CHAUDHARY, MAMDOOH GARI, MOHAMMED AL-QAHTANI and ASHRAF DALLOL
      Anticancer Research September 2011, 31 (9) 2975-2981;

  5. Adachi, MAKOTO

    1. Etodolac Improves 5-FU Sensitivity of Head and Neck Cancer Cells through Inhibition of Thymidylate Synthase
      SHOGO MURATA, MAKOTO ADACHI, MITOMU KIOI, SOICHIRO TORIGOE, KEI IJICHI, YASUHISA HASEGAWA, TETSUYA OGAWA, MIHIR K. BHAYANI, STEPHEN Y. LAI, KENJI MITSUDO and IWAI TOHNAI
      Anticancer Research September 2011, 31 (9) 2893-2898;

  6. Agostini, AUBERT

    1. Fertility-sparing Management of Grade 2 and 3 Endometrial Adenocarcinomas
      MARTIN KOSKAS, CHADI YAZBECK, FRANCINE WALKER, ELODIE CLOUQUEUR, AUBERT AGOSTINI, SANDRINE RUAT, JEAN PHILIPPE LUCOT, ERIC LAMBAUDIE, DOMINIQUE LUTON and PATRICK MADELENAT
      Anticancer Research September 2011, 31 (9) 3047-3049;

  7. Al-eisawi, ZAYNAB

    1. Modulation of Cisplatin Cytotoxicity due to its Combination with Bortezomib and the Nature of its Administration
      ZAYNAB AL-EISAWI, PHILIP BEALE, CHARLES CHAN, JUN QING YU and FAZLUL HUQ
      Anticancer Research September 2011, 31 (9) 2757-2762;

  8. Al-qahtani, MOHAMMED

    1. RASSF1A Methylation is Predictive of Poor Prognosis in Female Breast Cancer in a Background of Overall Low Methylation Frequency
      ABDELBASET BUHMEIDA, ADNAN MERDAD, JOUDAH EL-MAGHRABI, FATIMA AL-THOBAITI, MANAR ATA, AYMAN BUGIS, KARI SYRJÄNEN, ADEL ABUZENADAH, ADEEL CHAUDHARY, MAMDOOH GARI, MOHAMMED AL-QAHTANI and ASHRAF DALLOL
      Anticancer Research September 2011, 31 (9) 2975-2981;

  9. Al-thobaiti, FATIMA

    1. RASSF1A Methylation is Predictive of Poor Prognosis in Female Breast Cancer in a Background of Overall Low Methylation Frequency
      ABDELBASET BUHMEIDA, ADNAN MERDAD, JOUDAH EL-MAGHRABI, FATIMA AL-THOBAITI, MANAR ATA, AYMAN BUGIS, KARI SYRJÄNEN, ADEL ABUZENADAH, ADEEL CHAUDHARY, MAMDOOH GARI, MOHAMMED AL-QAHTANI and ASHRAF DALLOL
      Anticancer Research September 2011, 31 (9) 2975-2981;

  10. Alcaraz, JOHN E.

    1. Serum 25-Hydroxyvitamin D and Prevention of Breast Cancer: Pooled Analysis
      SHARIF B. MOHR, EDWARD D. GORHAM, JOHN E. ALCARAZ, CHRISTOPHER J. KANE, CAROLINE A. MACERA, J. KELLOGG PARSONS, DEBORAH L. WINGARD and CEDRIC F. GARLAND
      Anticancer Research September 2011, 31 (9) 2939-2948;
« Previous (Pages : 1 2 3 4 5 6 ... 49) Next »
Back to top

In this issue